EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Two-color flow cytometric analysis of CD34-positive peripheral blood stem cells mobilized by recombinant human granulocyte-colony stimulating factor for autotransplantation



Two-color flow cytometric analysis of CD34-positive peripheral blood stem cells mobilized by recombinant human granulocyte-colony stimulating factor for autotransplantation



Progress in Clinical and Biological Research 377: 561-567




(PDF emailed within 1 workday: $29.90)

Accession: 041880488

Download citation: RISBibTeXText

PMID: 1279725



Related references

Autotransplantation of peripheral blood stem cells mobilized by chemotherapy and recombinant human granulocyte colony-stimulating factor in childhood neuroblastoma and non-Hodgkin's lymphoma. British Journal of Haematology 80(3): 327-331, 1992

Recombinant human stem cell factor enhances the formation of colonies by cd34 positive and cd34 positive lin negative cells and the generation of colony forming cell progeny from cd34 positive lin negative cells cultured with interleukin 3 granulocyte colony stimulating factor or granulocyte macrophage colony stimulating factor. Blood 77(11): 2316-2321, 1991

Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood 84(8): 2795-2801, 1994

Circulating CD34 positive hematopoietic progenitors in the harvesting peripheral blood stem cells: Enhancement by recombinant human granulocyte colony-stimulating factor. Biotherapy (Dordrecht) 5(2): 131-136, 1992

Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood 89(4): 1189-1196, 1997

Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor. Blood 87(4): 1644-1653, 1996

Mean fluorescence intensity (MFI) of CD11b on CD34-positive (CD34+) cells derived from granulocyte colony-stimulating factor (G-CSF) mobilized peripheral blood (PB) correlate conversely with the total amount of harvested CD34+ cells. Annals of Hematology 81(8): 483-484, 2002

Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85(6): 1655-1658, 1995

Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates. Blood 85(1): 15-20, 1995

Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial. Biology of Blood and Marrow Transplantation 18(10): 1564-1572, 2013

Expression of adhesive receptors by bone marrow and peripheral blood CD34+ cells mobilized by granulocyte colony-stimulating factor quantitative analysis by flow cytometry. Blood 88(10 SUPPL 1 PART 1-2): 130B, 1996

Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte-colony stimulating factor. Bone Marrow Transplantation 10(4): 341-346, 1992

Potential benefit of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood stem cells for allogeneic transplantation. Blood 84(10): 3595-3596, 1994

Circulation of cd34 positive hematopoietic stem cells in the peripheral blood of high dose cyclosphosphamide treated patients enhancement by intravenous recombinant human granulocyte macrophage colony stimulating factor. Blood 74(6): 1905-1914, 1989